Joseph Edward Kerschner

Joseph Edward Kerschner

Auto-generated profile, based on publicly available information

Joseph Edward Kerschner

Medical College of Wisconsin, Children's Hospital of Wisconsin, 8915 West Connell Ct, Milwaukee, WI, 53226, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2001 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
JHJoseph K. Han
Joseph K. Han
JKJoseph E. Kerschner
Joseph E. Kerschner
THE NAME Streptococcus milleri was first proposed by Guthof in 19561 to describe gamma hemolytic streptococcus found in an oral cavity infection. Streptococcus milleri group (SMG) bacteria are microaerophilic bacteria categorized with viridans streptococci.2 Although different classifications have been used in referring to SMG bacteria, recently in the United States SMG bacteria have been divided into 3 different species3: Streptococcus intermedius, Streptococcus anginosus, and Streptococcus constellatus. The lack of uniformity in classifying these organisms, varying phenotypic traits, and the difficulty in culturing them have contributed to the lack of reports and relative unfamiliarity with SMG bacteria.4

1 September 2007 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
JKJoseph Edward Kerschner
Joseph Edward Kerschner

1 February 2002 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
JKJoseph E. Kerschner
Joseph E. Kerschner
JLJennifer B. Lynch
Jennifer B. Lynch
HKHarvey Kleiner
Harvey Kleiner
VFValerie A. Flanary
Valerie A. Flanary
TRTom B. Rice
Tom B. Rice

1 June 2001 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
JKJoseph E. Kerschner
Joseph E. Kerschner
DBDavid J. Beste
David J. Beste
SCStephen F. Conley
Stephen F. Conley
MKMargaret A. Kenna
Margaret A. Kenna
DLDennis Lee
Dennis Lee

1 January 2013 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
JKJoseph E. Kerschner
Joseph E. Kerschner
WHWenzhou Hong
Wenzhou Hong
STSteven R. Taylor
Steven R. Taylor
JKJohn A. Kerschner
John A. Kerschner
PKPawjai Khampang
Pawjai Khampang
PNPaula E. North
Paula E. North

1 June 2014 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
MOMallory B. O’niel
Mallory B. O’niel
CRChristina L. Runge
Christina L. Runge
DFDavid R. Friedland
David R. Friedland
JKJoseph E. Kerschner
Joseph E. Kerschner
Magnet-based implantable auditory assist devices (MIAADs) are a recent development in bone-anchored hearing devices (BAHD). The MIAAD used in this study is a transcutaneous bone conduction hearing system developed in Germany in 2006 and is a product of Sophono Inc. More than 100 patients have been implanted in Europe since its first use in Germany.1 The device was approved by the Food and Drug Administration for use in the United States in May 2011. In the United States, the first device implanted was in a 6-year-old child with bilateral atresia at our institution in June 2011. The device is approved for children 5 years or older, for those with conductive or mixed loss with bone conduction thresholds better than 45 dB, or for single-sided deafness with better-ear thresholds of less than 20 dB.